Waite Vision Compares Refractive Lens Exchange RLE Utah vs. CLR in New Blog Post
May 22, 2023 15:50 ET
|
Waite Vision
Lehi, May 22, 2023 (GLOBE NEWSWIRE) -- Lehi, Utah - Waite Vision, a vision correction practice in Lehi, UT, has recently published on their website an article titled, “Refractive Lens Exchange...
AiViva Biopharma Initiates Phase 1 Clinical Trial of AIV007 for Age-Related Macular Degeneration and Diabetic Macular Edema
May 22, 2023 06:00 ET
|
AiViva Biopharma
Novel JEL™ Technology for Periocular Administration COSTA MESA, Calif., May 22, 2023 (GLOBE NEWSWIRE) -- AiViva Biopharma Inc., a clinical-stage biotechnology company, announced that it has begun a...
Healthcare OEM Market Size Worth USD 214.90 Million by 2030 at 9.80% CAGR – Report by Market Research Future (MRFR)
May 17, 2023 12:45 ET
|
Market Research Future
New York, USA, May 17, 2023 (GLOBE NEWSWIRE) -- Healthcare OEM Market Overview According to a Comprehensive Research Report by Market Research Future (MRFR), “Healthcare OEM Market Information by...
CAR T-Cell Therapy Market to be Worth $51.6 Billion by 2030 - Exclusive Report by Meticulous Research®
May 16, 2023 10:00 ET
|
Meticulous Market Research Pvt. Ltd.
Redding, California, May 16, 2023 (GLOBE NEWSWIRE) -- According to a new market research report, ‘CAR T-Cell Therapy Market by Brand (Abecma [idecabtagene vicleucel], Breyanzi [lisocabtagene...
Abeona Therapeutics Announces New Preclinical Data from its AAV Ophthalmology Program at the 26th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
May 16, 2023 09:00 ET
|
Abeona Therapeutics Inc.
CLEVELAND, May 16, 2023 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced new data regarding three internally developed preclinical gene therapy product candidates from its...
4BIO Capital Portfolio Company Ray Therapeutics Closes Oversubscribed $100M Series A Financing to Advance Optogenetic Gene Therapies for Blinding Diseases
May 16, 2023 08:00 ET
|
4Bio Capital
Press Release 4BIO Capital Portfolio Company Ray Therapeutics Closes Oversubscribed $100M Series A Financing to Advance Optogenetic Gene Therapies for Blinding Diseases Series A follows initial seed...
Lumibird announces agreement to acquire Prima Industrie's high power laser and semiconductor businesses
May 16, 2023 01:30 ET
|
Lumibird SA
Lannion, 16/05/2023 - 7:30 am LUMIBIRD ANNOUNCES AGREEMENT TO ACQUIRE PRIMA INDUSTRIE'S HIGH POWER LASER AND SEMICONDUCTOR BUSINESSES IN ITALY AND THE UNITED STATES The LUMIBIRD Group (FR0000038242...
Iridex Reports First Quarter 2023 Financial Results
May 11, 2023 16:05 ET
|
IRIDEX Corporation
MOUNTAIN VIEW, Calif., May 11, 2023 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal...
MeiraGTx Reports First Quarter 2023 Financial and Operational Results
May 11, 2023 08:00 ET
|
MeiraGTx
Raised approximately $60 million in a private placement in May 2023 with investors consisting of several of the Company’s top shareholders On track for BLA submission of botaretigene sparoparvovec...
RVL Pharmaceuticals plc Reports First Quarter 2023 Financial Results; Provides Commercial Update
May 11, 2023 06:50 ET
|
RVL Pharmaceuticals plc
-- First quarter 2023 UPNEEQ® net product sales grew 49%, or $2.9 million, over the prior year period to $8.8 million -- -- Enhanced operating leverage with a 32%, or $7.9 million, reduction in...